Related Experiment Video
Updated: Jul 14, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
How to treat hypertension in patients with peripheral artery disease
Denis L Clement1, Marc L Debuyzere
1Department of the Dean, Ghent University Hospital, Building 3K3, 185, De Pintelaan, B-9000 Ghent, Belgium. denis.clement@UGent.be
Insights
Physicians often underestimate peripheral artery disease (PAD) risk, which hypertension exacerbates. Managing PAD and hypertension requires a focus on triple therapy and controlling total cardiovascular risk for better patient outcomes.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Peripheral artery disease (PAD) risk is frequently underestimated by physicians.
- Hypertension significantly increases the risk of peripheral artery disease.
- Early detection of PAD and hypertension is crucial for preventing cardiovascular events.
Purpose of the Study:
- To review the management of peripheral artery disease as a cardiovascular risk factor.
- To emphasize the importance of triple therapy in managing PAD.
- To discuss antihypertensive drug classes and their peripheral circulatory effects.
Main Methods:
- Literature review on PAD management and hypertension treatment.
- Analysis of the role of antiplatelet drugs, ACE inhibitors, and statins in triple therapy.
- Evaluation of antihypertensive medications concerning their impact on peripheral circulation.
Main Results:
- Triple therapy (antiplatelet drugs, angiotensin-converting enzyme inhibitors, statins) is highlighted for PAD management.
- Individual antihypertensive drugs show minimal differences in peripheral circulatory effects.
- Controlling total cardiovascular risk is paramount in patients with PAD and hypertension.
Conclusions:
- Effective management of PAD necessitates addressing associated risk factors like hypertension.
- A comprehensive approach to cardiovascular risk reduction is more critical than selecting specific antihypertensive agents.
- Physicians must improve PAD risk assessment and management strategies.
Abstract:
The risk of peripheral artery disease is underestimated by many physicians; such risk is further augmented by the presence of hypertension. Detection of these conditions is essential to prevent cardiovascular accidents. This review deals with the management of peripheral artery disease as a risk factor, highlighting the need for triple therapy (antiplatelet drugs, angiotensin-converting enzyme inhibitors, and statins). Treatment of hypertension is approached by reviewing the essentials of the different antihypertensive drugs available, focusing on their peripheral circulatory effect. However, because individual antihypertensive drugs seem not to differ largely in this respect, attention is drawn to the message that the most important task in these patients is to control total cardiovascular risk rather than focusing on the choice of the individual antihypertensive drug.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease I: Introduction